Computed tomography radiomics signature via machine learning predicts RRM2 and overall survival in hepatocellular carcinoma

被引:2
|
作者
Li, Qian [1 ]
Long, Xiawei [1 ]
Lin, Yan [1 ]
Liang, Rong [1 ]
Li, Yongqiang [1 ]
Ge, Lianying [2 ]
机构
[1] Guangxi Med Univ, Dept Med Oncol, Canc Hosp, Nanning, Peoples R China
[2] Guangxi Med Univ, Dept Endoscopy, Canc Hosp, Nanning, Peoples R China
关键词
Hepatocellular carcinoma (HCC); ribonucleotide reductase regulatory subunit M2 (RRM2); prediction model; radiomics; REDUCTASE; REPLICATION; INHIBITION; IMAGES;
D O I
10.21037/jgo-23-460
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Radiomics can be used to noninvasively predict molecular markers to address the clinical dilemma that some patients cannot accept invasive procedures. This research evaluated the prognostic significance of the expression level of ribonucleotide reductase regulatory subunit M2 (RRM2) in individuals with hepatocellular carcinoma (HCC) and established a radiomics model for predicting the RRM2 expression level. Methods: Genomic data for HCC patients and corresponding computed tomography (CT) images were accessed at The Cancer Genome Atlas (TCGA) and The Cancer Imaging Archive (TCIA), which were utilized for prognosis analysis, radiomic feature extraction and model construction, respectively. The maximum relevance minimum redundancy algorithm (mRMR) and recursive feature elimination (RFE) were used for feature selection. Following feature extraction, a logistic regression algorithm was fitted to establish a dichotomous model that predicts RRM2 gene expression. Establishment of the radiomics nomogram was carried out using the Cox regression model. Receiver operating characteristic (ROC) curve analysis was employed to assess the model performance. Clinical utility was determined by decision curve analysis (DCA). Results: High RRM2 expression acted as a risk factor for overall survival (OS) [hazard ratio (HR) =2.083, P<0.001] and was implicated in regulation of the immune response. Four optimal radiomics features were selected for prediction of RRM2 expression. A predictive nomogram was established using the clinical variables and radiomics score (RS), and the areas under the ROC curve (AUCs) of the time-dependent ROC curve of the model were 0.836, 0.757, and 0.729 for the 1-, 3-, and 5-year periods, respectively. DCA confirmed that the nomogram had good clinical usefulness. Conclusions: The RRM2 expression level in HCC can considerably affect prognosis of these patients. Expression levels of RRM2 and prognosis of HCC individuals can be predicted through radiomics features by utilizing CT scan data.
引用
收藏
页码:1462 / 1477
页数:16
相关论文
共 50 条
  • [1] Deep learning radiomics based on contrast enhanced computed tomography predicts microvascular invasion and survival outcome in early stage hepatocellular carcinoma
    Yang, Yuhan
    Zhou, Yin
    Zhou, Chen
    Ma, Xuelei
    EJSO, 2022, 48 (05): : 1068 - 1077
  • [2] Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma
    Deng, Peng-Zhan
    Zhao, Bi-Geng
    Huang, Xian-Hui
    Xu, Ting-Feng
    Chen, Zi-Jun
    Wei, Qiu-Feng
    Liu, Xiao-Yi
    Guo, Yu-Qi
    Yuan, Sheng-Guang
    Liao, Wei-Jia
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (31) : 4376 - 4389
  • [3] Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma
    Peng-Zhan Deng
    Bi-Geng Zhao
    Xian-Hui Huang
    Ting-Feng Xu
    Zi-Jun Chen
    Qiu-Feng Wei
    Xiao-Yi Liu
    Yu-Qi Guo
    Sheng-Guang Yuan
    Wei-Jia Liao
    World Journal of Gastroenterology, 2022, (31) : 4376 - 4389
  • [4] A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma
    Wang, Zhigang
    Pan, Leyu
    Guo, Deliang
    Luo, Xiaofeng
    Tang, Jie
    Yang, Weihua
    Zhang, Yuxian
    Luo, Anni
    Gu, Yang
    Pan, Yuxuan
    CANCER MEDICINE, 2021, 10 (11): : 3808 - 3821
  • [5] A 6-microbial signature risk score for overall survival prediction in hepatocellular carcinoma: a machine learning approach
    Al-Bzour, Nour N.
    Al-Bzour, Ayah N.
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Machine Learning Identifies a Signature of Nine Exosomal RNAs That Predicts Hepatocellular Carcinoma
    Yap, Josephine Yu Yan
    Goh, Laura Shih Hui
    Lim, Ashley Jun Wei
    Chong, Samuel S. S.
    Lim, Lee Jin
    Lee, Caroline G. G.
    CANCERS, 2023, 15 (14)
  • [7] Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma
    Qin, Zhongqiang
    Xie, Bo
    Qian, Jingyu
    Ma, Xiang
    Zhang, Lan
    Wei, Jianzhu
    Wang, Zhaoying
    Fan, Longfei
    Zhu, Ziyi
    Qian, Zhen
    Yin, Hongxiang
    Zhu, Fangquan
    Tan, Yulin
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [8] A Novel Amino Acid-Related Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma
    Wang, Shuyi
    Huang, Hong
    Hu, Xingwang
    Xiao, Meifang
    Yang, Kaili
    Bu, Haiyan
    Jiang, Yupeng
    Huang, Zebing
    CANCER REPORTS, 2024, 7 (07)
  • [9] Seven-senescence-associated gene signature predicts overall survival for Asian patients with hepatocellular carcinoma
    Xiao-Hong Xiang
    Li Yang
    Xing Zhang
    Xiao-Hua Ma
    Run-Chen Miao
    Jing-Xian Gu
    Yu-Nong Fu
    Qing Yao
    Jing-Yao Zhang
    Chang Liu
    Ting Lin
    Kai Qu
    World Journal of Gastroenterology, 2019, 25 (14) : 1715 - 1728
  • [10] An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma
    Li, Wenli
    Lu, Jianjun
    Ma, Zhanzhong
    Zhao, Jiafeng
    Liu, Jun
    FRONTIERS IN GENETICS, 2020, 10